Faculty
Kai Wang, Ph.D.
Professor of Pathology and Laboratory Medicine
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations
Contact information
3501 Civic Center Blvd, CTRB 6004
Children's Hospital of Philadelphia
Philadelphia, PA 19104
Children's Hospital of Philadelphia
Philadelphia, PA 19104
Office: 2674259573
Fax: 2155903660
Fax: 2155903660
Education
B.S. (Biochemistry & Molecular Biology)
Peking University, 2000.
M.S. (Tumor Biology)
Mayo Clinic, 2002.
Ph.D. (Microbiology & Computational Biology)
University of Washington, 2005.
Permanent linkB.S. (Biochemistry & Molecular Biology)
Peking University, 2000.
M.S. (Tumor Biology)
Mayo Clinic, 2002.
Ph.D. (Microbiology & Computational Biology)
University of Washington, 2005.
Description of Research Expertise
The research in our laboratory aims to develop novel genomics and bioinformatics methods to improve the diagnosis, treatment, and prognosis of rare diseases, to ultimately facilitate the implementation genomic medicine on scale. A detailed description of our research and rotation projects can be found on our lab website (https://wglab.org). In summary, our research can be divided into several areas.First, we are developing analytical pipelines for whole genome and whole exome sequencing data, all the way from FASTQ/FAST5/POD5 files to biological insights. Some examples of computational tools include ANNOVAR, InterVar, CancerVar, Phenolyzer, Phen2Gene and PhenoSV. These approaches enhance the interpretation of sequencing data by uncovering functional content and providing clinically relevant insights.
Furthermore, we are developing genomic assays and methods to analyze long-read data, such as those generated from PacBio and Oxford Nanopore sequencing. These methods aid in identifying causal genetic variants in cases that elude diagnosis by traditional whole genome or exome sequencing and enable the detection of aberrant DNA and RNA methylation patterns. Some examples of computational tools include RepeatHMM, LinkedSV, ContextSV, NanoRepeat, LIQA, DeepMod and DeepMod2.
Finally, we are developing Artificial Intelligence (AI) and Machine Learning (ML) approaches to correlate genotype with phenotype, and to better understand the phenotypic heterogeneity of inherited diseases. We believe that multimodal AI holds the potential to transform our understanding of biology and medicine—what remains is to develop the right algorithms to fully harness its power. Some examples of computational tools include EHR-Phenolyzer, PhenoGPT, MutFormer and GestaltMML.
Selected Publications
Xu Z, Qu HQ, Chan J, Mu S, Kao C, Hakonarson H, Wang K.: SCOTCH: isoform-level characterization of gene expression through long-read single-cell RNA sequencing. Nat Commun May 2026.Wang P, Wang K: PubMind: Literature-Based Genetic Variant Extraction and Functional Annotation Using Large Language Models. Nat Commun 17(1): 9962, Aug 2026.
Liang Y, Zhang G, Babb L, Rehm HL, Nestor JG, Kneifati-Hayek JZ, Luo Y, Murthy SBK, Shen Y, Wang K*, Chung WK*, Weng C*: Temporal analysis of clinical variant reclassification (2012–2025). Genome Med 2026.
Zhang Y, Ahsan MU, Wang P, Lin X, Campbell IM, Liu C, Chung WK, Weng C, Wang K.: RankVar: machine learning-based variant ranking and reinterpretation for rare genetic diseases Genome Med 18(1): 139, Jul 2026.
Rybacki K, Cha ENY, Deutsch HM, Gaudet E, Ahsan MU, Xu F, Chan J, Li M, Song Y, Wang K: Long-Read Transcriptome Sequencing and Functional Validation Reveals Novel and Oncogenic Gene Fusions in Fusion Panel-Negative Gliomas. Genome Med 2026.
Nguyen QM, Chen F, Liu C, Campbell IM, Zhang G, Wu D, Szigety KM, Sheppard SE, Ahimaz P, Ta CN, Chung WK, Weng C, Wang K.: Interpretable fine-tuned large language models facilitate making genetic test decisions for rare diseases. NPJ Digit Med May 2026.
Wu D, Wang Z, Nguyen Q, Xu Z, Wang K: Multimodal Integrated Knowledge Transfer to Large Language Models through Preference Optimization with Biomedical Applications. Patterns 7(8): 101544, May 2026.
Zhang Y, Ahsan MU, Wang K.: Noncoding de novo mutations in SCN2A are associated with autism spectrum disorders. iScience 28: 113258, Aug 2025.
Zou Y, Ahsan MU, Chan J, Meng W, Gao SJ, Huang Y, Wang K.: A comparative evaluation of computational models for RNA modification detection using nanopore sequencing with RNA004 chemistry. Brief Bioinform 26: bbaf404, Jul 2025.
Gracia-Diaz C, Perdomo JE, Khan ME, Roule T, Disanza BL, Cajka GG, Lei S, Gagne AL, Maguire JA, Shalem O, Bhoj EJ, Ahrens-Nicklas RC, French DL, Goldberg EM, Wang K, Glessner JT, Akizu N.: KOLF2.1J iPSCs carry CNVs associated with neurodevelopmental disorders. Cell Stem Cell 31: 288-289, Mar 2024.
Yang J, Liu C, Deng W, Wu D, Weng C, Zhou Y, Wang K.: Enhancing phenotype recognition in clinical notes using large language models: PhenoBCBERT and PhenoGPT. Patterns (N Y) 5: 100887, Dec 2023.
Ahsan MU, Gouru A, Chan J, Zhou W, Wang K.: A signal processing and deep learning framework for methylation detection using Oxford Nanopore sequencing. Nat Commun 15: 1448, Feb 2024.
Xu Z, Li Q, Marchionni L, Wang K.: PhenoSV: interpretable phenotype-aware model for the prioritization of genes affected by structural variants. Nat Commun 14: 7805, Nov 2023.
Jiang TT, Fang L, Wang K.: Deciphering "the language of nature": A transformer-based language model for deleterious mutations in proteins. Innovation (Camb) 4: 100487, Jul 2023.
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.